BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luther DC, Huang R, Jeon T, Zhang X, Lee YW, Nagaraj H, Rotello VM. Delivery of drugs, proteins, and nucleic acids using inorganic nanoparticles. Adv Drug Deliv Rev 2020;156:188-213. [PMID: 32610061 DOI: 10.1016/j.addr.2020.06.020] [Cited by in Crossref: 66] [Cited by in F6Publishing: 52] [Article Influence: 33.0] [Reference Citation Analysis]
Number Citing Articles
1 Cun D, Zhang C, Bera H, Yang M. Particle engineering principles and technologies for pharmaceutical biologics. Adv Drug Deliv Rev 2021;174:140-67. [PMID: 33845039 DOI: 10.1016/j.addr.2021.04.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
2 Liang J, Zhao X. Nanomaterial-based delivery vehicles for therapeutic cancer vaccine development. Cancer Biol Med 2021:j. [PMID: 33979069 DOI: 10.20892/j.issn.2095-3941.2021.0004] [Reference Citation Analysis]
3 Jia X, Lv M, Fei Y, Dong Q, Wang H, Liu Q, Li D, Wang J, Wang E. Facile one-step synthesis of NIR-Responsive siRNA-Inorganic hybrid nanoplatform for imaging-guided photothermal and gene synergistic therapy. Biomaterials 2022;282:121404. [DOI: 10.1016/j.biomaterials.2022.121404] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gao Q, Zhang J, Gao J, Zhang Z, Zhu H, Wang D. Gold Nanoparticles in Cancer Theranostics. Front Bioeng Biotechnol 2021;9:647905. [PMID: 33928072 DOI: 10.3389/fbioe.2021.647905] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 dos Santos J, Oliveira RS, Oliveira TV, Velho MC, Konrad MV, da Silva GS, Deon M, Beck RCR. 3D Printing and Nanotechnology: A Multiscale Alliance in Personalized Medicine. Adv Funct Mater 2021;31:2009691. [DOI: 10.1002/adfm.202009691] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 17.0] [Reference Citation Analysis]
6 Ray M, Brancolini G, Luther DC, Jiang Z, Cao-Milán R, Cuadros AM, Burden A, Clark V, Rana S, Mout R, Landis RF, Corni S, Rotello VM. High affinity protein surface binding through co-engineering of nanoparticles and proteins. Nanoscale 2022. [PMID: 35089292 DOI: 10.1039/d1nr07497k] [Reference Citation Analysis]
7 Chien HW, Yang CH, Shih YT, Wang TL. Upconversion Nanoparticles Encapsulated with Molecularly Imprinted Amphiphilic Copolymer as a Fluorescent Probe for Specific Biorecognition. Polymers (Basel) 2021;13:3522. [PMID: 34685278 DOI: 10.3390/polym13203522] [Reference Citation Analysis]
8 Li X, Shao Y, Lv S, Tian J, Zheng D, Song J, Song F. Au@mSiO2 core-shell nanoparticles loaded with fluorescent dyes: synthesis and application for imaging performance. Dalton Trans 2021;50:5624-31. [PMID: 33908961 DOI: 10.1039/d1dt00253h] [Reference Citation Analysis]
9 Luther DC, Jeon T, Goswami R, Nagaraj H, Kim D, Lee YW, Rotello VM. Protein Delivery: If Your GFP (or Other Small Protein) Is in the Cytosol, It Will Also Be in the Nucleus. Bioconjug Chem 2021;32:891-6. [PMID: 33872490 DOI: 10.1021/acs.bioconjchem.1c00103] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Liu R, Feng Y, Li Z, Lu S, Guan T, Li X, Liu Y, Chen Z, Chen X. A Novel Near-infrared Responsive Lanthanide Upconversion Nanoplatform for Drug Delivery Based on Photocleavage of Cypate . Acta Chimica Sinica 2022;80:423. [DOI: 10.6023/a22010001] [Reference Citation Analysis]
11 Yoo YJ, Lee CH, Park SH, Lim YT. Nanoparticle-based delivery strategies of multifaceted immunomodulatory RNA for cancer immunotherapy. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.01.047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Deloney M, Garoosi P, Dartora VFC, Christiansen BA, Panitch A. Hyaluronic Acid-Binding, Anionic, Nanoparticles Inhibit ECM Degradation and Restore Compressive Stiffness in Aggrecan-Depleted Articular Cartilage Explants. Pharmaceutics 2021;13:1503. [PMID: 34575579 DOI: 10.3390/pharmaceutics13091503] [Reference Citation Analysis]
13 Le VT, Ngu NNQ, Chau TP, Nguyen TD, Nguyen VT, Nguyen TLH, Cao XT, Doan V, Karimi-maleh H. Silver and Gold Nanoparticles from Limnophila rugosa Leaves: Biosynthesis, Characterization, and Catalytic Activity in Reduction of Nitrophenols. Journal of Nanomaterials 2021;2021:1-11. [DOI: 10.1155/2021/5571663] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Ftouh M, Kalboussi N, Abid N, Sfar S, Mignet N, Bahloul B. Contribution of Nanotechnologies to Vaccine Development and Drug Delivery against Respiratory Viruses. PPAR Res 2021;2021:6741290. [PMID: 34721558 DOI: 10.1155/2021/6741290] [Reference Citation Analysis]
15 Li Y, Xiao Y, Chen Y, Huang K. Nano-based approaches in the development of antiviral agents and vaccines. Life Sci 2021;265:118761. [PMID: 33189824 DOI: 10.1016/j.lfs.2020.118761] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Selvakesavan RK, Franklin G. Prospective Application of Nanoparticles Green Synthesized Using Medicinal Plant Extracts as Novel Nanomedicines. Nanotechnol Sci Appl 2021;14:179-95. [PMID: 34588770 DOI: 10.2147/NSA.S333467] [Reference Citation Analysis]
17 Dhankher A, Lv W, Studstill WT, Champion JA. Coiled coil exposure and histidine tags drive function of an intracellular protein drug carrier. J Control Release 2021;339:248-58. [PMID: 34563592 DOI: 10.1016/j.jconrel.2021.09.026] [Reference Citation Analysis]
18 Chang TC, Tanaka K. In vivo organic synthesis by metal catalysts. Bioorg Med Chem 2021;46:116353. [PMID: 34419820 DOI: 10.1016/j.bmc.2021.116353] [Reference Citation Analysis]
19 Chen S, Li J, Ma X, Liu F, Yan G. Cationic Peptide-Modified Gold Nanostars as Efficient Delivery Platform for RNA Interference Antitumor Therapy. Polymers (Basel) 2021;13:3764. [PMID: 34771323 DOI: 10.3390/polym13213764] [Reference Citation Analysis]
20 Ji W, Li Y, Peng H, Zhao R, Zhang X. Nature-inspired dynamic gene-loaded nanoassemblies for the treatment of brain diseases. Adv Drug Deliv Rev 2022;180:114029. [PMID: 34752841 DOI: 10.1016/j.addr.2021.114029] [Reference Citation Analysis]
21 Peña Q, Wang A, Zaremba O, Shi Y, Scheeren HW, Metselaar JM, Kiessling F, Pallares RM, Wuttke S, Lammers T. Metallodrugs in cancer nanomedicine. Chem Soc Rev 2022. [PMID: 35262108 DOI: 10.1039/d1cs00468a] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
22 Li X, Li W, Wang M, Liao Z. Magnetic nanoparticles for cancer theranostics: Advances and prospects. J Control Release 2021;335:437-48. [PMID: 34081996 DOI: 10.1016/j.jconrel.2021.05.042] [Reference Citation Analysis]
23 Han M, Beon J, Lee JY, Oh SS. Systematic Combination of Oligonucleotides and Synthetic Polymers for Advanced Therapeutic Applications. Macromol Res 2021;29:665-80. [PMID: 34754286 DOI: 10.1007/s13233-021-9093-5] [Reference Citation Analysis]
24 Zoulikha M, He W. Targeted Drug Delivery for Chronic Lymphocytic Leukemia. Pharm Res. [DOI: 10.1007/s11095-022-03214-0] [Reference Citation Analysis]
25 Chang T, Vong K, Yamamoto T, Tanaka K. Prodrug Activation by Gold Artificial Metalloenzyme‐Catalyzed Synthesis of Phenanthridinium Derivatives via Hydroamination. Angew Chem Int Ed 2021;60:12446-54. [DOI: 10.1002/anie.202100369] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
26 Kim JW, Lee KK, Park KW, Kim M, Lee CS. Genetically Modified Ferritin Nanoparticles with Bone-Targeting Peptides for Bone Imaging. Int J Mol Sci 2021;22:4854. [PMID: 34063731 DOI: 10.3390/ijms22094854] [Reference Citation Analysis]
27 Baghbanbashi M, Kakkar A. Polymersomes: Soft Nanoparticles from Miktoarm Stars for Applications in Drug Delivery. Mol Pharm 2022. [PMID: 35157463 DOI: 10.1021/acs.molpharmaceut.1c00928] [Reference Citation Analysis]
28 Yao S, Wang Y, Chi J, Yu Y, Zhao Y, Luo Y, Wang Y. Porous MOF Microneedle Array Patch with Photothermal Responsive Nitric Oxide Delivery for Wound Healing. Adv Sci (Weinh) 2022;9:e2103449. [PMID: 34783460 DOI: 10.1002/advs.202103449] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
29 Naszályi Nagy L, Dhaene E, Van Zele M, Mihály J, Klébert S, Varga Z, Kövér KE, De Buysser K, Van Driessche I, Martins JC, Fehér K. Silica@zirconia Core@shell Nanoparticles for Nucleic Acid Building Block Sorption. Nanomaterials (Basel) 2021;11:2166. [PMID: 34578482 DOI: 10.3390/nano11092166] [Reference Citation Analysis]
30 Hindy OA, Goker M, Yilgor Huri P. Nanoscale agents within 3D-printed constructs: intersection of nanotechnology and personalized bone tissue engineering. emergent mater . [DOI: 10.1007/s42247-022-00366-y] [Reference Citation Analysis]
31 Griffith JI, Rathi S, Zhang W, Zhang W, Drewes LR, Sarkaria JN, Elmquist WF. Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors. Pharmaceutics 2020;12:E1205. [PMID: 33322488 DOI: 10.3390/pharmaceutics12121205] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
32 Asghar S, Khan IU, Salman S, Khalid SH, Ashfaq R, Vandamme TF. Plant-derived nanotherapeutic systems to counter the overgrowing threat of resistant microbes and biofilms. Adv Drug Deliv Rev 2021;179:114019. [PMID: 34699940 DOI: 10.1016/j.addr.2021.114019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Liang M, Li J, Han L. Receptor-mediated cascade targeting strategies for the application to medical diagnoses and therapeutics of glioma. J Nanopart Res 2022;24. [DOI: 10.1007/s11051-022-05482-8] [Reference Citation Analysis]
34 Wang W, Zhang X, Huang R, Hirschbiegel CM, Wang H, Ding Y, Rotello VM. In situ activation of therapeutics through bioorthogonal catalysis. Adv Drug Deliv Rev 2021;176:113893. [PMID: 34333074 DOI: 10.1016/j.addr.2021.113893] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
35 Chang T, Vong K, Yamamoto T, Tanaka K. Prodrug Activation by Gold Artificial Metalloenzyme‐Catalyzed Synthesis of Phenanthridinium Derivatives via Hydroamination. Angew Chem 2021;133:12554-62. [DOI: 10.1002/ange.202100369] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
36 Luther DC, Nagaraj H, Goswami R, Çiçek YA, Jeon T, Gopalakrishnan S, Rotello VM. Direct Cytosolic Delivery of Proteins Using Lyophilized and Reconstituted Polymer-Protein Assemblies. Pharm Res 2022. [PMID: 35297498 DOI: 10.1007/s11095-022-03226-w] [Reference Citation Analysis]
37 Zhao Z, Zhang Z, Duan S, Liu X, Zhou R, Hou M, Sang Y, Zhu R, Yin L. Cytosolic protein delivery via metabolic glycoengineering and bioorthogonal click reactions. Biomater Sci 2021;9:4639-47. [PMID: 34036971 DOI: 10.1039/d1bm00548k] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Ye QN, Wang Y, Shen S, Xu CF, Wang J. Biomaterials-Based Delivery of Therapeutic Antibodies for Cancer Therapy. Adv Healthc Mater 2021;10:e2002139. [PMID: 33870637 DOI: 10.1002/adhm.202002139] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
39 Capocefalo A, Deckert-Gaudig T, Brasili F, Postorino P, Deckert V. Unveiling the interaction of protein fibrils with gold nanoparticles by plasmon enhanced nano-spectroscopy. Nanoscale 2021;13:14469-79. [PMID: 34473176 DOI: 10.1039/d1nr03190b] [Reference Citation Analysis]
40 Zhang Y, Hu M, Zhang W, Zhang X. Construction of tellurium-doped mesoporous bioactive glass nanoparticles for bone cancer therapy by promoting ROS-mediated apoptosis and antibacterial activity. J Colloid Interface Sci 2021:S0021-9797(21)02032-4. [PMID: 34848060 DOI: 10.1016/j.jcis.2021.11.122] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Muhsen HO, Almayyali AOM, Al-Mamoori AY, Mahmood FF. Theoretical analysis of the structural and electronic properties of the interaction of boron nitride diamantane nanocrystal with the drug hydroxyurea as an anticancer drug. J Mol Model 2021;27:90. [PMID: 33611723 DOI: 10.1007/s00894-021-04711-6] [Reference Citation Analysis]
42 Huang R, Luther DC, Zhang X, Gupta A, Tufts SA, Rotello VM. Engineering the Interface between Inorganic Nanoparticles and Biological Systems through Ligand Design. Nanomaterials (Basel) 2021;11:1001. [PMID: 33924735 DOI: 10.3390/nano11041001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Brenner JS, Mitragotri S, Muzykantov VR. Red Blood Cell Hitchhiking: A Novel Approach for Vascular Delivery of Nanocarriers. Annu Rev Biomed Eng 2021;23:225-48. [PMID: 33788581 DOI: 10.1146/annurev-bioeng-121219-024239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Zeng L, Shi W, Wang H, Cheng X, Chen T, Wang LL, Lan J, Sun W, Liu M, Zhang X, Zhang J, Chen J. Codelivery of π-π Stacked Dual Anticancer Drugs Based on Aloe-Derived Nanovesicles for Breast Cancer Therapy. ACS Appl Mater Interfaces 2022;14:27686-702. [PMID: 35675505 DOI: 10.1021/acsami.2c06546] [Reference Citation Analysis]
45 Tian Y, Tirrell MV, LaBelle JL. Harnessing the Therapeutic Potential of Biomacromolecules through Intracellular Delivery of Nucleic Acids, Peptides, and Proteins. Adv Healthc Mater 2022;:e2102600. [PMID: 35285167 DOI: 10.1002/adhm.202102600] [Reference Citation Analysis]
46 Yan J, Kang DD, Turnbull G, Dong Y. Delivery of CRISPR-Cas9 system for screening and editing RNA binding proteins in cancer. Adv Drug Deliv Rev 2022;180:114042. [PMID: 34767864 DOI: 10.1016/j.addr.2021.114042] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Bhattacharya T, Das D, Borges e Soares GA, Chakrabarti P, Ai Z, Chopra H, Hasan MA, Cavalu S. Novel Green Approaches for the Preparation of Gold Nanoparticles and Their Promising Potential in Oncology. Processes 2022;10:426. [DOI: 10.3390/pr10020426] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
48 Valente SA, Silva LM, Lopes GR, Sarmento B, Coimbra MA, Passos CP. Polysaccharide-based formulations as potential carriers for pulmonary delivery - A review of their properties and fates. Carbohydr Polym 2022;277:118784. [PMID: 34893219 DOI: 10.1016/j.carbpol.2021.118784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
49 Wang D, Peng R, Peng Y, Deng Z, Xu F, Su Y, Wang P, Li L, Wang X, Ke Y, Tan W. Hierarchical Fabrication of DNA Wireframe Nanoarchitectures for Efficient Cancer Imaging and Targeted Therapy. ACS Nano 2020;14:17365-75. [DOI: 10.1021/acsnano.0c07495] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
50 Delello Di Filippo L, Hofstätter Azambuja J, Paes Dutra JA, Tavares Luiz M, Lobato Duarte J, Nicoleti LR, Olalla Saad ST, Chorilli M. Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers. Eur J Pharm Biopharm 2021;168:76-89. [PMID: 34461214 DOI: 10.1016/j.ejpb.2021.08.011] [Reference Citation Analysis]
51 Quadros M, Momin M, Verma G. Design strategies and evolving role of biomaterial assisted treatment of osteosarcoma. Mater Sci Eng C Mater Biol Appl 2021;121:111875. [PMID: 33579498 DOI: 10.1016/j.msec.2021.111875] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
52 Li L, Sun R, Zheng R. Tunable morphology and functionality of multicomponent self-assembly: A review. Materials & Design 2021;197:109209. [DOI: 10.1016/j.matdes.2020.109209] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 17.0] [Reference Citation Analysis]
53 Yang Y, Liu Y, Tu D, Chen M, Zhang Y, Gao H, Chen X. Tumor-Microenvironment-Responsive Biodegradable Nanoagents Based on Lanthanide Nucleotide Self-Assemblies toward Precise Cancer Therapy. Angew Chem Int Ed Engl 2022;61:e202116983. [PMID: 35084798 DOI: 10.1002/anie.202116983] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
54 Kashapov R, Ibragimova A, Pavlov R, Gabdrakhmanov D, Kashapova N, Burilova E, Zakharova L, Sinyashin O. Nanocarriers for Biomedicine: From Lipid Formulations to Inorganic and Hybrid Nanoparticles. Int J Mol Sci 2021;22:7055. [PMID: 34209023 DOI: 10.3390/ijms22137055] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Yang C, Lin ZI, Chen JA, Xu Z, Gu J, Law WC, Yang JHC, Chen CK. Organic/Inorganic Self-Assembled Hybrid Nano-Architectures for Cancer Therapy Applications. Macromol Biosci 2021;:e2100349. [PMID: 34735739 DOI: 10.1002/mabi.202100349] [Reference Citation Analysis]
56 Nayl AA, Abd-elhamid AI, Aly AA, Bräse S. Recent progress in the applications of silica-based nanoparticles. RSC Adv 2022;12:13706-26. [DOI: 10.1039/d2ra01587k] [Reference Citation Analysis]